XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis

Detalles Bibliográficos
Autores principales: Boons, Eline, Nogueira, Tatiane C., Dierckx, Tim, Menezes, Soraya Maria, Jacquemyn, Maarten, Tamir, Sharon, Landesman, Yosef, Farré, Lourdes, Bittencourt, Achiléa, Kataoka, Keisuke, Ogawa, Seishi, Snoeck, Robert, Andrei, Graciela, Van Weyenbergh, Johan, Daelemans, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873181/
https://www.ncbi.nlm.nih.gov/pubmed/33563902
http://dx.doi.org/10.1038/s41408-021-00409-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873181/
https://www.ncbi.nlm.nih.gov/pubmed/33563902
http://dx.doi.org/10.1038/s41408-021-00409-3

Ejemplares similares